Treatment Options for Juvenile Pityriasis Rubra Pilaris-Reference-Cited by-同舟云学术

Treatment Options for Juvenile Pityriasis Rubra Pilaris

Published:2022-12-18 Issue:2 Volume:25 Page:151-164
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatr Drugs

Author:

Guenther Jana,Novack Danielle,Kamath Sonia,Worswick Scott^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s40272-022-00549-4.pdf

Reference121 articles.

1. Kromer C, Sabat R, Celis D, Mössner R. Systemic therapies of pityriasis rubra pilaris: a systematic review. J Dtsch Dermatol Ges. 2019;17(3):243–59. https://doi.org/10.1111/DDG.13718.

2. Gelmetti C, Schiuma AA, Cerri D, Gianotti F. Pityriasis rubra pilaris in childhood: a long-term study of 29 cases. Pediatr Dermatol. 1986;3(6):446–51. https://doi.org/10.1111/J.1525-1470.1986.TB00648.X.

3. Davidson CL, Winkelmann RK, Kierland RR. Pityriasis rubra pilaris: a follow-up study of 57 patients. Arch Dermatol. 1969;100(2):175–8. https://doi.org/10.1001/ARCHDERM.1969.01610260051008.

4. Sorensen KB, Thestrup-Pedersen K. Pityriasis rubra pilaris: a retrospective analysis of 43 patients. Acta Derm Venereol. 1999;79(5):405–6. https://doi.org/10.1080/000155599750010517.

5. Larregue M, Champion R, Bressieux JM, Laidet B, Lorette G. Acute pityriasis rubra pilaris in the child: apropos of 4 cases. Ann Dermatol Venereol. 1983;110(3):221–8.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid clearance of extensive juvenile pityriasis rubra pilaris with ixekizumab;Pediatric Dermatology;2024-07-24

2. Successful treatment of erythrodermic pityriasis rubra pilaris with upadacitinib;Journal of the European Academy of Dermatology and Venereology;2023-12-16

3. Successful treatment of CARD14‐negative juvenile Pityriasis rubra pilaris with Ustekinumab;Journal of the European Academy of Dermatology and Venereology;2023-12-12

4. Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukast;Frontiers in Medicine;2023-11-30